DIANA TOLLAKSEN: Open Payments
NPI 1356422927 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 16 payments from 12 companies in 2025. Trend: 2023 $429 · 2024 $227 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Davol Inc. | 2 | $216 |
| Viatris Specialty LLC | 1 | $123 |
| Abbott Laboratories | 3 | $123 |
| Gilead Sciences, Inc. | 1 | $121 |
| Neurelis, Inc. | 1 | $115 |
| Actelion Pharmaceuticals US, Inc. | 1 | $113 |
| Pacira Pharmaceuticals Incorporated | 1 | $58 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $33 |
| Arteriocyte Medical Systems, Inc. | 1 | $32 |
| Averitas Pharma Inc. | 1 | $24 |
Products named: ARISTA, YUPELRI, VALTOCO, UPTRAVI, AXIUM, Iovera, PROCLAIM, JOURNAVX.
Industry payments across VA — which companies pay providers there.
